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after a ﬁrst episode of SAH. Screening may prevent new
episodes of SAH but might also lead to higher morbidity
rates because of diagnosis and treatment related com-
plications. Further clinical studies are required to ﬁll 
the gaps detected, and costs should be balanced against
effects.
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OBJECTIVES: Stenting of the arteria carotis interna
(CAS) is becoming an increasingly popular means of
treating carotid stenosis. At present however costs of
stents are high and conclusive trials to prove the (equal)
effectiveness of CAS as compared to carotid endarterec-
tomy (CEA) are not ﬁnalized yet. The primary goal of the
current study is to assess the uncertainties concerning
long- and short-term clinical outcomes on the cost-
effectiveness analysis of CAS verses CAE. METHODS: A
Markov model was constructed to assess the cost-
effectiveness for carotid treatment for the Dutch setting
based on clinical data published in literature and in-house
collected cost data. RESULTS: The procedural costs for
the CAS procedure are 15% higher than costs for a CEA.
Major stroke is a dominating factor in both quality of life
and in follow-up costs. Therefore the short- and long-
term results of the cost-beneﬁt analysis will be highly
inﬂuenced by the perioperative and post-operative inci-
dence rates for major stroke. This idea is supported by
model sensitivity analyses who show that the sensitivity
to the long-term incidence rate is two times higher than
the short-term incidence rate. As the level of uncertainty
of the long-term major stroke rates are higher than those
of the perioperative stroke rates, these will clearly domi-
nate the level of uncertainty regarding the decision on 
the cost-effectiveness of the CAS procedure. CONCLU-
SIONS: The results show that the uncertainties concern-
ing the long-term major stroke risks have a predominant
inﬂuence on the outcome of the evaluation of the cost-
effectiveness of CAS over CEA. Therefore, long-term
effects need to be assessed and considered before a 
balanced decision on the cost-effectiveness of the CAS
over the CEA procedure can be taken.
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OBJECTIVES: Patients with Heart Failure (HF) are
known to be noncompliant and can also suffer from poor
HRQoL. We wanted to determine whether compliance
inﬂuenced HRQoL scores. We used the SF-36 and com-
pliance scores of patients with HF to examine this ques-
tion. METHODS: These data are from a RCT of patients
with HF (n = 134) who were assigned to a usual care arm
(U) or an enhanced intervention arm (I) and followed for
one year. Improvement in HRQoL was considered as an
increase in 10 points in the PCS or MCS summary scales
of the SF-36, which we considered to be reﬂective of 
a minimal clinically important difference (MCID) for
patients. Patients who had an overall compliance score
between 0.8 and 1.2 were considered compliant. Patients
who had an overall compliance <0.8 or >1.2 were deemed
non-compliant. Using a logistic regression model with
compliance as the dependent variable we entered HRQoL
data and ARM allocation. RESULTS: The odds ratio of
associated with a 10-point increase in PCS was 1.63 for
compliance relative to non-compliance (CI 1.06–2.51) p
= 0.026. The odds ratio associated with a 10-point
increase in MCS was 1.26 (CI 0.868–1.83) p (ns). When
we include the ARM in the model the odds ratio is 1.58
(CI > 1.02–2.45), p = 0.040. CONCLUSIONS: There is
a statistically signiﬁcant relationship (p < 0.05) between
HRQoL and compliance, where 1.63 can be interpreted
as the change in odds of compliance relative to non-
compliance that is associated with a 10-point change in
the PCS score of the SF-36. These ﬁndings help us inter-
pret HRQoL data by including HRQoL as a mediating
variable that affects outcomes such as compliance that are
known to have a signiﬁcant impact on patients with HF.
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OBJECTIVES: Patients with HF suffer from poor health
related quality of life (HRQoL). In this randomized con-
trolled trial we used both generic (SF-36, HUI Mark 2/3)
and disease speciﬁc (MLHFQ) measures of HRQoL to
determine whether our educational intervention had any
impact on these outcomes. METHODS: Patients with 
HF were stratiﬁed by reason for admission and then 
randomized to receive either usual care (U) or an educa-
tional intervention (I). HRQoL was a secondary outcome
measure in this trial. All patients were measured at base-
line and every three months to one year. RESULTS: In 
the SF-36 there was a trend at certain visit numbers in
physical functioning (p = 0.081), role limitation due to
physical problems (p = 0.032), role limitation due to emo-
tional problems (p = 0.068) and energy vitality (p =
0.068). There were no differences over time between each
